ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC36828-10mg |
|
— |
Oxaprozin D4
|
0 | C18H11D4NO3 | |
GC36828-5mg |
|
— |
Oxaprozin D4
|
0 | C18H11D4NO3 | |
GC36828-1mg |
|
— |
Oxaprozin D4
|
0 | C18H11D4NO3 | |
GC36826-10mg |
|
— |
OVA G4 peptide TFA
|
0 | C45H72F3N9O14 | |
GC36826-5mg |
|
— |
OVA G4 peptide TFA
|
0 | C45H72F3N9O14 | |
GC36826-1mg |
|
— |
OVA G4 peptide TFA
|
0 | C45H72F3N9O14 | |
GC36825-10mg |
|
148274-82-2 |
OVA G4 peptide
|
0 | C43H71N9O12 | |
GC36825-5mg |
|
148274-82-2 |
OVA G4 peptide
|
0 | C43H71N9O12 | |
GC36825-1mg |
|
148274-82-2 |
OVA G4 peptide
|
0 | C43H71N9O12 | |
GC36823-10mg |
|
364071-17-0 |
OT-R antagonist 1
|
0 | C28H29N3O4 | |
GC36823-5mg |
|
364071-17-0 |
OT-R antagonist 1
|
0 | C28H29N3O4 | |
GC36823-1mg |
|
364071-17-0 |
OT-R antagonist 1
|
0 | C28H29N3O4 | |
GC36821-50mg |
|
2070015-22-2 |
OSU-T315
|
0 | C30H30F3N5O | |
GC36821-10mg |
|
2070015-22-2 |
OSU-T315
|
0 | C30H30F3N5O | |
GC36821-5mg |
|
2070015-22-2 |
OSU-T315
|
0 | C30H30F3N5O | |
GC36821-2mg |
|
2070015-22-2 |
OSU-T315
|
0 | C30H30F3N5O | |
GC36821-10mM (in 1mL DMSO) |
|
2070015-22-2 |
OSU-T315
|
0 | C30H30F3N5O | |
GC36820-100mg |
|
841205-47-8 |
Ostarine
|
0 | C19H14F3N3O3 | |
GC36820-50mg |
|
841205-47-8 |
Ostarine
|
0 | C19H14F3N3O3 | |
GC36820-10mg |
|
841205-47-8 |
Ostarine
|
0 | C19H14F3N3O3 | |